Alhambra Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,248
| Closed | -$689K | – | 146 |
|
|
2022
Q4 | $689K | Sell |
5,248
-65
| -1% | -$8.53K | 0.5% | 60 |
|
|
2022
Q3 | $621K | Buy |
5,313
+62
| +1% | +$7.25K | 0.47% | 62 |
|
|
2022
Q2 | $618K | Buy |
5,251
+370
| +8% | +$43.5K | 0.45% | 65 |
|
|
2022
Q1 | $636K | Buy |
4,881
+696
| +17% | +$90.7K | 0.42% | 69 |
|
|
2021
Q4 | $639K | Buy |
4,185
+557
| +15% | +$85K | 0.45% | 73 |
|
|
2021
Q3 | $586K | Buy |
3,628
+167
| +5% | +$27K | 0.45% | 73 |
|
|
2021
Q2 | $566K | Buy |
3,461
+168
| +5% | +$27.5K | 0.42% | 76 |
|
|
2021
Q1 | $496K | Buy |
3,293
+348
| +12% | +$52.4K | 0.4% | 79 |
|
|
2020
Q4 | $446K | Buy |
2,945
+149
| +5% | +$22.6K | 0.48% | 71 |
|
|
2020
Q3 | $379K | Buy |
+2,796
| New | +$379K | 0.46% | 75 |
|